Microneedle for nosocomial skin infections
Drug-resistant bacteria cause nosocomial skin infections. New devices are necessary to facilitate local antibiotic delivery and improve drug efficiency. To provide proof-of-concept, the EU-funded HOTSKIN project will assess the technical and commercial feasibility of a device for nosocomial skin infection treatment. This hybrid microneedle patch penetrates difficult-to-infiltrate skin layers to deliver antibiotics and raise the local temperature to enhance drug effectiveness, obviating the need for high dosage systemic drug administration. The device can bolster the use of antibacterial drugs for the topical treatment of skin infections with improved dermatological delivery. HOTSKIN will validate the device’s fabrication process for additional commercial scalability and functionality with nanocarrier-drug complexes and also conduct extensive market analysis.
Fields of science
Funding SchemeERC-POC-LS - ERC Proof of Concept Lump Sum Pilot
See on map
171 65 Solna
See on map